Back
Sage Therapeutics Vs. Poseida Therapeutics Industry Stock Comparison
Sell
34
SAGE
Sage Therapeutics
Last Price:
$5.61
Seasonality Move:
0.25%
Sell
48
PSTX
Poseida Therapeutics
Last Price:
$9.47
Seasonality Move:
-14.94%
Sell
34
Sage Therapeutics (SAGE)
is a Sell
Is Sage Therapeutics a Buy, Sell or Hold?
-
The current Sage Therapeutics [SAGE] share price is $5.61. The Score for SAGE is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
-
SAGE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Poseida Therapeutics (PSTX)
is a Sell
Is Poseida Therapeutics a Buy, Sell or Hold?
-
The current Poseida Therapeutics [PSTX] share price is $9.47. The Score for PSTX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
PSTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SAGE Stock Price Chart
What is Sage Therapeutics's stock price today?
-
The Sage Therapeutics share price today is $5.61The current trend is relatively stagnant and SAGE is experiencing buying pressure, which is a positive indicator for future bullish movement.
PSTX Stock Price Chart
What is Poseida Therapeutics's stock price today?
-
The Poseida Therapeutics share price today is $9.47Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PSTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
SAGE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.18 | Sell |
Relative Strength Index (14 RSI): | 50.27 | Buy |
Chaikin Money Flow: | 4207089 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.05 - 5.69) | Buy |
Bollinger Bands (100): | (5.7 - 8.24) | Sell |
PSTX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.35 | Buy |
Relative Strength Index (14 RSI): | 86.15 | Buy |
Chaikin Money Flow: | 1458989 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.55 - 10.55) | Buy |
Bollinger Bands (100): | (1.49 - 6.57) | Buy |
SAGE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.4 | Buy |
20-day SMA: | 5.49 | Buy |
50-day SMA: | 6.08 | Sell |
200-day SMA: | 10.31 | Sell |
8-day EMA: | 5.36 | Buy |
20-day EMA: | 5.49 | Buy |
50-day EMA: | 6.05 | Sell |
200-day EMA: | 10.88 | Sell |
PSTX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 9.48 | Sell |
20-day SMA: | 8.76 | Buy |
50-day SMA: | 5.12 | Buy |
200-day SMA: | 3.48 | Buy |
8-day EMA: | 9.39 | Buy |
20-day EMA: | 8.35 | Buy |
50-day EMA: | 6.21 | Buy |
200-day EMA: | 3.98 | Buy |
Sage Therapeutics Earnings Growth & SAGE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.49 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.10 per share, and an increase next year of $2.77 per share.
Poseida Therapeutics Earnings Growth & PSTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.75 per share, and a decrease next year of $1.08 per share.
Sage Therapeutics Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Poseida Therapeutics Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |